Biomedical & Medtech Manufacturing
WuXi Biologics (Singapore)
UNCLAIMED RECORD · Claim it →Building a roughly US$1.4 billion integrated CRDMO on a 13.5-hectare Tuas site adding 120,000 litres of biologics capacity and about 1,500 jobs, offering end-to-end drug-substance and drug-product (fill-finish) services across monoclonal antibodies, bispecifics and recombinant proteins on single-use technology.
Capabilities
Sources
CLAIM THIS RECORD
Is this your company?
WuXi Biologics (Singapore) is on the Singapore Industry Index as a reference record, compiled from public sources. Claiming it is free — correct the facts, add capabilities and certifications, appear on more pages, and receive enquiries routed directly to you.
Spotted an error? Claiming is the fastest way to fix it — or write to us via Contact.